Ectopic expression of X-linked lymphocyte-regulated protein pM1 renders tumor cells resistant to antitumor immunity

Cancer Research

Volumn 70, Issue 8, 2010, Pages 3062-3070

  Kang, Tae Heung ^a,b   Noh, Kyung Hee ^a   Kim, Jin Hee ^a   Bae, Hyun Cheol ^a   Lin, Ken Y ^c   Monie, Archana ^b   Pai, Sara I ^b   Hung, Chien Fu ^b   Wu, T C ^b   Kim, Tae Woo ^a  

^a Korea University College of Medicine   (South Korea)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; MEIOSIS REGULATED PROTEIN; PROTEIN KINASE B; SYNAPTONEMAL COMPLEX PROTEIN 3; UNCLASSIFIED DRUG; X LINKED LYMPHOCYTE REGULATED PROTEIN PM1;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE; GENETIC TRANSDUCTION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNAPTONEMAL COMPLEX; TUMOR IMMUNITY; UTERINE CERVIX CANCER; XLR GENE;

ANIMALS; APOPTOSIS; FEMALE; GENES, X-LINKED; HUMANS; IMMUNE SYSTEM; IMMUNOTHERAPY; LYMPHOCYTES; MICE; MICE, INBRED C57BL; NEOPLASMS; NUCLEAR PROTEINS;

EID: 77951055906     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-3856     Document Type: Article

References (22)

1. Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: moving beyond current vaccines. Nat Med 2004;10:909-915 (Pubitemid 39273730)
2. Lin KY, Guarnieri FG, Staveley-O'Carroll KF, et al. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res 1996;56:21-26
3. Wu TC. The role of vascular cell adhesion molecule-1 in tumor immune evasion. Cancer Res 2007;67:6003-6006
4. Wu TC, Guarnieri FG, Staveley-O'Carroll KF, et al. Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens. Proc Natl Acad Sci U S A 1995;92:11671-11675
5. Noh KH, Kang TH, Kim JH, et al. Activation of Akt as a mechanism for tumor immune evasion. Mol Ther 2008;17:439-447
6. Lin KY, Lu D, Hung CF, et al. Ectopic expression of vascular cell adhesion molecule-1 as a new mechanism for tumor immune evasion. Cancer Res 2007;67:1832-1841 (Pubitemid 46383410)
7. Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003;4:249-264
8. Kendziorski CM, Newton MA, Lan H, Gould MN. On parametric empirical Bayes methods for comparing multiple groups using replicated gene expression profiles. Stat Med 2003;22:3899-3914 (Pubitemid 38008708)
9. Newton MA, Kendziorski CM, Richmond CS, Blattner FR, Tsui KW. On differential variability of expression ratios: improving statistical inference about gene expression changes from microarray data. J Comput Biol 2001;8:37-52.
10. Bloom MB, Perry-Lalley D, Robbins PF, et al. Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma. J Exp Med 1997;185:453-459 (Pubitemid 27078363)
11. Hung CF, Cheng WF, He L, et al. Enhancing major histocompatibility complex class I antigen presentation by targeting antigen to centrosomes. Cancer Res 2003;63:2393-2398 (Pubitemid 36605174)
12. Cheng WF, Hung CF, Chai CY, et al. Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J Clin Invest 2001;108:669-678 (Pubitemid 32906195)
13. Chen CH, Wang TL, Hung CF, et al. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res 2000;60:1035-1042
14. Hung CF, Cheng WF, Hsu KF, et al. Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen. Cancer Res 2001;61:3698-3703
15. Han HD, Song CK, Park YS, et al. A chitosan hydrogel-based cancer drug delivery system exhibits synergistic antitumor effects by combining with a vaccinia viral vaccine. Int J Pharm 2008;350:27-34.
16. Yang L, Dan HC, Sun M, et al. Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt. Cancer Res 2004;64:4394-4399 (Pubitemid 38856907)
17. Calenda A, Allenet B, Escalier D, Bach JF, Garchon HJ. The meiosis-specific Xmr gene product is homologous to the lymphocyte Xlr protein and is a component of the XY body. EMBO J 1994;13:100-109 (Pubitemid 24017179)
18. Lammers JH, Offenberg HH, van Aalderen M, Vink AC, Dietrich AJ, Heyting C. The gene encoding a major component of the lateral elements of synaptonemal complexes of the rat is related to X-linked lymphocyte-regulated genes. Mol Cell Biol 1994;14:1137-1146 (Pubitemid 24036564)
19. Garchon HJ. The Xlr (X-linked lymphocyte regulated) gene family (a candidate locus for an X-linked primary immune deficiency). Immunodefic Rev 1991;2:283-302.
20. Siegel JN, Turner CA, Klinman DM, et al. Sequence analysis and expression of an X-linked, lymphocyte-regulated gene family (XLR). J Exp Med 1987;166:1702-1715
21. Franke TF. PI3K/Akt: getting it right matters. Oncogene 2008;27:6473-6488
22. Du K, Tsichlis PN. Regulation of the Akt kinase by interacting proteins. Oncogene 2005;24:7401-7409 (Pubitemid 41637980)